BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19362386)

  • 1. Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients.
    Pan SH; Chao YC; Chen HY; Hung PF; Lin PY; Lin CW; Chang YL; Wu CT; Lee YC; Yang SC; Hong TM; Yang PC
    Lung Cancer; 2010 Jan; 67(1):93-100. PubMed ID: 19362386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1.
    Pan SH; Chao YC; Hung PF; Chen HY; Yang SC; Chang YL; Wu CT; Chang CC; Wang WL; Chan WK; Wu YY; Che TF; Wang LK; Lin CY; Lee YC; Kuo ML; Lee CH; Chen JJ; Hong TM; Yang PC
    J Clin Invest; 2011 Aug; 121(8):3189-205. PubMed ID: 21747164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of LCRMP-1 by GSK3β promotes filopoda formation, migration and invasion abilities in lung cancer cells.
    Wang WL; Hong TM; Chang YL; Wu CT; Pan SH; Yang PC
    PLoS One; 2012; 7(2):e31689. PubMed ID: 22363707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.
    Oliemuller E; Peláez R; Garasa S; Pajares MJ; Agorreta J; Pío R; Montuenga LM; Teijeira A; Llanos S; Rouzaut A
    Int J Cancer; 2013 May; 132(9):1986-95. PubMed ID: 23023514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells.
    Shih JY; Yang SC; Hong TM; Yuan A; Chen JJ; Yu CJ; Chang YL; Lee YC; Peck K; Wu CW; Yang PC
    J Natl Cancer Inst; 2001 Sep; 93(18):1392-400. PubMed ID: 11562390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis.
    Chang CC; Shih JY; Jeng YM; Su JL; Lin BZ; Chen ST; Chau YP; Yang PC; Kuo ML
    J Natl Cancer Inst; 2004 Mar; 96(5):364-75. PubMed ID: 14996858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator of G-protein signaling 4: A novel tumor suppressor with prognostic significance in non-small cell lung cancer.
    Cheng C; Yue W; Li L; Li S; Gao C; Si L; Tian H
    Biochem Biophys Res Commun; 2016 Jan; 469(3):384-91. PubMed ID: 26640232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the expression profiles of excision repair crosscomplementation group 1, x-ray repair crosscomplementation group 1, and betaIII-tubulin between primary non-small cell lung cancer and metastatic lymph nodes and the significance in mid-term survival.
    Kang CH; Jang BG; Kim DW; Chung DH; Kim YT; Jheon S; Sung SW; Kim JH
    J Thorac Oncol; 2009 Nov; 4(11):1307-12. PubMed ID: 19745766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
    Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer.
    Huang G; Song H; Wang R; Han X; Chen L
    J Surg Oncol; 2012 Mar; 105(4):420-4. PubMed ID: 21780128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
    Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
    Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS.
    Zhang X; Yu X; Jiang G; Miao Y; Wang L; Zhang Y; Liu Y; Fan C; Lin X; Dong Q; Han Q; Zhao H; Han Y; Han X; Rong X; Ding S; Wang E; Wang E
    Cancer Res; 2015 Nov; 75(21):4527-37. PubMed ID: 26359454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancer.
    Bai XY; Lin JY; Zhang XC; Xie Z; Yan HH; Chen ZH; Xu CR; An SJ; Sheng GM; Wu YL
    Cancer Biomark; 2013; 13(1):37-47. PubMed ID: 23736020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.